Loading…

An admission medication reconciliation programme carried out by pharmacists: impact on surgeons' prescriptions

ObjectivesTo describe a medication reconciliation (MR) procedure prepared by the pharmacist for patients admitted for elective surgery and to assess the surgeon’s degree of acceptance.MethodsA 1-year retrospective observational study was conducted. The patient population consisted of patients aged ≥...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2018-03, Vol.25 (e1), p.e62-e65
Main Authors: Arenas-Villafranca, José Javier, Moreno-Santamaría, Manuela, López Gómez, Carmen, Muñoz Gómez-Millán, Isabel, Álvaro Sanz, Elena, Tortajada-Goitia, Begoña
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ObjectivesTo describe a medication reconciliation (MR) procedure prepared by the pharmacist for patients admitted for elective surgery and to assess the surgeon’s degree of acceptance.MethodsA 1-year retrospective observational study was conducted. The patient population consisted of patients aged ≥18 years admitted during 2016 for elective surgery and whose planned length of hospital stay was >24 hours. A pharmacist performed MR following a specific protocol. A review of the reconciliations prescribed later by the surgeons was conducted. Statistical analyses were performed for qualitative and quantitative variables.ResultsThe pharmacist prepared a total of 1986 reconciliation reports. The 179 patients reviewed in this study had a mean age of 65.7±11.8 years, 49.2% were women and 98.9% of patients were reconciled by the surgeon in the operating theatre using an electronic prescribing system (85.5% were fully reconciled).ConclusionThe hospital’s MR protocol resulted in almost 100% of patients being reconciled within the subgroup of elective surgery patients by the prescribing surgeons.
ISSN:2047-9956
2047-9964
DOI:10.1136/ejhpharm-2017-001392